Joey Bose, our CEO and President, breaks down why researchers have called A2M the ‘physiological guardian.’ A2M, or alpha-2-macroglobulin, is a natural protein found in your bloodstream that acts like a bodyguard against inflammation and joint destruction. It works as a broad-spectrum protease inhibitor and also sequesters cytokines – the same inflammatory signals you heard so much about during COVID. At Cytonics, we’re harnessing this powerful protein in our next-generation therapy, CYT-108, designed to target osteoarthritis at its root cause, not just mask the pain. This is science built to protect your joints from the inside out.
Hello,
I’m Joey Bose, CEO of Cytonics
I started this blog to track our drug development journey as we take on the Boogeyman of regenerative medicine – osteoarthritis (OA). If successful, we will have developed the first and only “true” disease-modifying treatment for OA, succeeding where Big Pharma has repeatedly failed, and forever changing the lives of 600M suffering people worldwide. And if that wasn’t enough, we will have done so without a dime of Venture Capital or institutional support. Cytonics is a company For the People, By the People, and we are extremely proud of our grassroots approach to biopharmceutical development! Want to get involved? invest.cytonics.com
Leave a Reply